воскресенье, 18 декабря 2016 г.

Better Buy: Juno Therapeutics vs. Alnylam Pharmaceuticals

Better Buy: Juno Therapeutics vs. Alnylam Pharmaceuticals


Both biotechs have also lost over half of their market cap since then beginning of 2016. Which of these two stocks is the better pick for investors now? Here's how Juno and Alnylam stack up.



from Biotech News